世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

オランザピン錠剤の世界市場成長 2023-2029


Global Olanzapine Tablets Market Growth 2023-2029

オランザピン錠の世界市場規模は2022年の百万米ドルから2029年には百万米ドルに成長すると予測されており、2023年から2029年までの年平均成長率は%であると予測されている。 オランザピン錠の米国市場は、2022年... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2023年6月23日 US$3,660
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		116 英語

　

サマリー

オランザピン錠の世界市場規模は2022年の百万米ドルから2029年には百万米ドルに成長すると予測されており、2023年から2029年までの年平均成長率は%であると予測されている。
オランザピン錠の米国市場は、2022年の百万米ドルから2029年には百万米ドルに増加し、2023年から2029年までの年平均成長率は％と予測される。
オランザピン錠の中国市場は、2023年から2029年までの年平均成長率%で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定される。
オランザピン錠のヨーロッパ市場は、2023年から2029年までの年平均成長率%で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定される。
オランザピン錠剤の世界的な主要企業は、Lilly、Dr. Reddy's Laboratories、Apotex、Torrent Pharmaceuticals Ltd.、Teva Pharmaceutical、Jiangsu Hansoh Pharmaceutical Group Co.Ltd.、QILU Pharmaceutical Co.Ltd.、Changzhou Watson Pharmaceuticals Co.Ltd.、Sichuan Kelun Pharmaceutical Co.Ltd.などです。売上高では、2022年に世界の大手2社がほぼ％のシェアを占めている。
オランザピン錠は、オランザピンを有効成分とする医薬品である。統合失調症、双極性障害、その他関連する精神疾患の治療に用いられる抗精神病薬である。
脳内の様々な神経伝達物質、特にドーパミンとセロトニンの活性を調節することにより、精神症状や気分の落ち込みを軽減します。
LPI（エルピーアイ情報）の最新調査レポート「オランザピン錠剤の産業予測」は、過去の売上高に注目し、2022年の世界のオランザピン錠剤の総売上高をレビューし、2023年から2029年までのオランザピン錠剤の予測売上高を地域別・市場分野別に包括的に分析しています。オランザピン錠剤の売上高を地域別、市場分野別、サブセクター別に分類し、世界のオランザピン錠剤産業の詳細な分析を百万米ドル単位で提供しています。
本インサイトレポートでは、世界のオランザピン錠剤の状況を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動などに関する主要動向を明らかにしています。また本レポートでは、Olanzapine Tabletsのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析し、加速する世界のOlanzapine Tablets市場におけるこれらの企業の独自の地位をより良く理解しています。
当インサイトレポートでは、オランザピン錠の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に分類して予測を行い、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界のオランザピン錠剤の現状と将来の軌道について非常にニュアンスのある見解を提供します。
当レポートでは、オランザピン錠剤市場の製品タイプ別、用途別、主要メーカー別、主要地域別および国別の包括的な概要、市場シェア、成長機会を紹介しています。
市場のセグメンテーション
タイプ別セグメンテーション
2.5mg/錠剤
5mg/錠剤
10mg/錠
用途別セグメント
病院
診療所
小売薬局
その他
本レポートは地域別にも市場を分割しています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
リリー
ドクター・レディーズ・ラボラトリーズ
アポテックス
トーレント・ファーマシューティカルズ
テバ・ファーマシューティカル
江蘇漢創薬業集団有限公司
麒麟製薬股份有限公司
常州ワトソン製薬有限公司
四川ケルン製薬有限公司
浙江華海医薬有限公司
江蘇日華医薬有限公司
PKUヘルスケア社
成都東方生物医薬有限公司
サンシャイン湖医薬有限公司
合肥英泰医薬有限公司
蘇州第三製薬工場有限公司
江蘇海安薬業有限公司
本レポートで扱う主な質問
世界のオランザピン錠剤市場の10年見通しは？
世界および地域別のオランザピン錠市場成長の要因は何か？
市場別・地域別に最も急成長する技術は何か？
オランザピン錠剤の市場機会は最終市場規模によってどのように異なるのか？
オランザピン錠剤のタイプ、用途別の内訳は？
COVID-19とロシア・ウクライナ戦争の影響は？


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Olanzapine Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Olanzapine Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Olanzapine Tablets by Country/Region, 2018, 2022 & 2029
2.2 Olanzapine Tablets Segment by Type
2.2.1 2.5mg/tablet
2.2.2 5mg/tablet
2.2.3 10mg/tablet
2.3 Olanzapine Tablets Sales by Type
2.3.1 Global Olanzapine Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Olanzapine Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Olanzapine Tablets Sale Price by Type (2018-2023)
2.4 Olanzapine Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Olanzapine Tablets Sales by Application
2.5.1 Global Olanzapine Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Olanzapine Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Olanzapine Tablets Sale Price by Application (2018-2023)
3 Global Olanzapine Tablets by Company
3.1 Global Olanzapine Tablets Breakdown Data by Company
3.1.1 Global Olanzapine Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Olanzapine Tablets Sales Market Share by Company (2018-2023)
3.2 Global Olanzapine Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Olanzapine Tablets Revenue by Company (2018-2023)
3.2.2 Global Olanzapine Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Olanzapine Tablets Sale Price by Company
3.4 Key Manufacturers Olanzapine Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Olanzapine Tablets Product Location Distribution
3.4.2 Players Olanzapine Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Olanzapine Tablets by Geographic Region
4.1 World Historic Olanzapine Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Olanzapine Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Olanzapine Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Olanzapine Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Olanzapine Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Olanzapine Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Olanzapine Tablets Sales Growth
4.4 APAC Olanzapine Tablets Sales Growth
4.5 Europe Olanzapine Tablets Sales Growth
4.6 Middle East & Africa Olanzapine Tablets Sales Growth
5 Americas
5.1 Americas Olanzapine Tablets Sales by Country
5.1.1 Americas Olanzapine Tablets Sales by Country (2018-2023)
5.1.2 Americas Olanzapine Tablets Revenue by Country (2018-2023)
5.2 Americas Olanzapine Tablets Sales by Type
5.3 Americas Olanzapine Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Olanzapine Tablets Sales by Region
6.1.1 APAC Olanzapine Tablets Sales by Region (2018-2023)
6.1.2 APAC Olanzapine Tablets Revenue by Region (2018-2023)
6.2 APAC Olanzapine Tablets Sales by Type
6.3 APAC Olanzapine Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Olanzapine Tablets by Country
7.1.1 Europe Olanzapine Tablets Sales by Country (2018-2023)
7.1.2 Europe Olanzapine Tablets Revenue by Country (2018-2023)
7.2 Europe Olanzapine Tablets Sales by Type
7.3 Europe Olanzapine Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Olanzapine Tablets by Country
8.1.1 Middle East & Africa Olanzapine Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Olanzapine Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Olanzapine Tablets Sales by Type
8.3 Middle East & Africa Olanzapine Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Olanzapine Tablets
10.3 Manufacturing Process Analysis of Olanzapine Tablets
10.4 Industry Chain Structure of Olanzapine Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Olanzapine Tablets Distributors
11.3 Olanzapine Tablets Customer
12 World Forecast Review for Olanzapine Tablets by Geographic Region
12.1 Global Olanzapine Tablets Market Size Forecast by Region
12.1.1 Global Olanzapine Tablets Forecast by Region (2024-2029)
12.1.2 Global Olanzapine Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Olanzapine Tablets Forecast by Type
12.7 Global Olanzapine Tablets Forecast by Application
13 Key Players Analysis
13.1 Lilly
13.1.1 Lilly Company Information
13.1.2 Lilly Olanzapine Tablets Product Portfolios and Specifications
13.1.3 Lilly Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Lilly Main Business Overview
13.1.5 Lilly Latest Developments
13.2 Dr. Reddy's Laboratories
13.2.1 Dr. Reddy's Laboratories Company Information
13.2.2 Dr. Reddy's Laboratories Olanzapine Tablets Product Portfolios and Specifications
13.2.3 Dr. Reddy's Laboratories Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dr. Reddy's Laboratories Main Business Overview
13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Olanzapine Tablets Product Portfolios and Specifications
13.3.3 Apotex Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Torrent Pharmaceuticals Ltd.
13.4.1 Torrent Pharmaceuticals Ltd. Company Information
13.4.2 Torrent Pharmaceuticals Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.4.3 Torrent Pharmaceuticals Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Torrent Pharmaceuticals Ltd. Main Business Overview
13.4.5 Torrent Pharmaceuticals Ltd. Latest Developments
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Information
13.5.2 Teva Pharmaceutical Olanzapine Tablets Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Main Business Overview
13.5.5 Teva Pharmaceutical Latest Developments
13.6 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.6.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
13.6.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.6.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
13.6.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
13.7 QILU Pharmaceutical Co., Ltd.
13.7.1 QILU Pharmaceutical Co., Ltd. Company Information
13.7.2 QILU Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.7.3 QILU Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 QILU Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 QILU Pharmaceutical Co., Ltd. Latest Developments
13.8 Changzhou Watson Pharmaceuticals Co., Ltd.
13.8.1 Changzhou Watson Pharmaceuticals Co., Ltd. Company Information
13.8.2 Changzhou Watson Pharmaceuticals Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.8.3 Changzhou Watson Pharmaceuticals Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Changzhou Watson Pharmaceuticals Co., Ltd. Main Business Overview
13.8.5 Changzhou Watson Pharmaceuticals Co., Ltd. Latest Developments
13.9 Sichuan Kelun Pharmaceutical Co.,Ltd.
13.9.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
13.9.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.9.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business Overview
13.9.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
13.10 Zhejiang Huahai Pharmaceutical Co., Ltd.
13.10.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
13.10.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.10.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Latest Developments
13.11 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
13.11.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information
13.11.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.11.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Main Business Overview
13.11.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Latest Developments
13.12 PKU HealthCare Corp.,Ltd.
13.12.1 PKU HealthCare Corp.,Ltd. Company Information
13.12.2 PKU HealthCare Corp.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.12.3 PKU HealthCare Corp.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 PKU HealthCare Corp.,Ltd. Main Business Overview
13.12.5 PKU HealthCare Corp.,Ltd. Latest Developments
13.13 Chengdu Easton Biopharmaceuticals Co.,Ltd.
13.13.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Information
13.13.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.13.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Main Business Overview
13.13.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Latest Developments
13.14 Sunshine Lake Pharma Co., Ltd.
13.14.1 Sunshine Lake Pharma Co., Ltd. Company Information
13.14.2 Sunshine Lake Pharma Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.14.3 Sunshine Lake Pharma Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sunshine Lake Pharma Co., Ltd. Main Business Overview
13.14.5 Sunshine Lake Pharma Co., Ltd. Latest Developments
13.15 Hefei Yingtai Pharmaceutical Co., Ltd.
13.15.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.15.2 Hefei Yingtai Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.15.3 Hefei Yingtai Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.16 Suzhou No.3 Pharmaceutical Factory Co.,Ltd.
13.16.1 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Company Information
13.16.2 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.16.3 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Main Business Overview
13.16.5 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Latest Developments
13.17 Jiangsu Haian Pharmaceutical Co., Ltd.
13.17.1 Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
13.17.2 Jiangsu Haian Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.17.3 Jiangsu Haian Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Jiangsu Haian Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Jiangsu Haian Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

The global Olanzapine Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Olanzapine Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Olanzapine Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Olanzapine Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Olanzapine Tablets players cover Lilly, Dr. Reddy's Laboratories, Apotex, Torrent Pharmaceuticals Ltd., Teva Pharmaceutical, Jiangsu Hansoh Pharmaceutical Group Co., Ltd., QILU Pharmaceutical Co., Ltd., Changzhou Watson Pharmaceuticals Co., Ltd. and Sichuan Kelun Pharmaceutical Co.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Olanzapine Tablets is a medicine that contains olanzapine as an active ingredient. It is an antipsychotic drug used to treat schizophrenia, bipolar disorder, and other related mental illnesses.
It reduces mental symptoms and mood swings by regulating the activity of various neurotransmitters in the brain, especially the activities of dopamine and serotonin.
LPI (LP Information)' newest research report, the “Olanzapine Tablets Industry Forecast” looks at past sales and reviews total world Olanzapine Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Olanzapine Tablets sales for 2023 through 2029. With Olanzapine Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Olanzapine Tablets industry.
This Insight Report provides a comprehensive analysis of the global Olanzapine Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Olanzapine Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Olanzapine Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Olanzapine Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Olanzapine Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Olanzapine Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
2.5mg/tablet
5mg/tablet
10mg/tablet
Segmentation by application
Hospital
Clinic
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lilly
Dr. Reddy's Laboratories
Apotex
Torrent Pharmaceuticals Ltd.
Teva Pharmaceutical
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
QILU Pharmaceutical Co., Ltd.
Changzhou Watson Pharmaceuticals Co., Ltd.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
PKU HealthCare Corp.,Ltd.
Chengdu Easton Biopharmaceuticals Co.,Ltd.
Sunshine Lake Pharma Co., Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Suzhou No.3 Pharmaceutical Factory Co.,Ltd.
Jiangsu Haian Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Olanzapine Tablets market?
What factors are driving Olanzapine Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Olanzapine Tablets market opportunities vary by end market size?
How does Olanzapine Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Olanzapine Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Olanzapine Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Olanzapine Tablets by Country/Region, 2018, 2022 & 2029
2.2 Olanzapine Tablets Segment by Type
2.2.1 2.5mg/tablet
2.2.2 5mg/tablet
2.2.3 10mg/tablet
2.3 Olanzapine Tablets Sales by Type
2.3.1 Global Olanzapine Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Olanzapine Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Olanzapine Tablets Sale Price by Type (2018-2023)
2.4 Olanzapine Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Olanzapine Tablets Sales by Application
2.5.1 Global Olanzapine Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Olanzapine Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Olanzapine Tablets Sale Price by Application (2018-2023)
3 Global Olanzapine Tablets by Company
3.1 Global Olanzapine Tablets Breakdown Data by Company
3.1.1 Global Olanzapine Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Olanzapine Tablets Sales Market Share by Company (2018-2023)
3.2 Global Olanzapine Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Olanzapine Tablets Revenue by Company (2018-2023)
3.2.2 Global Olanzapine Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Olanzapine Tablets Sale Price by Company
3.4 Key Manufacturers Olanzapine Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Olanzapine Tablets Product Location Distribution
3.4.2 Players Olanzapine Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Olanzapine Tablets by Geographic Region
4.1 World Historic Olanzapine Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Olanzapine Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Olanzapine Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Olanzapine Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Olanzapine Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Olanzapine Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Olanzapine Tablets Sales Growth
4.4 APAC Olanzapine Tablets Sales Growth
4.5 Europe Olanzapine Tablets Sales Growth
4.6 Middle East & Africa Olanzapine Tablets Sales Growth
5 Americas
5.1 Americas Olanzapine Tablets Sales by Country
5.1.1 Americas Olanzapine Tablets Sales by Country (2018-2023)
5.1.2 Americas Olanzapine Tablets Revenue by Country (2018-2023)
5.2 Americas Olanzapine Tablets Sales by Type
5.3 Americas Olanzapine Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Olanzapine Tablets Sales by Region
6.1.1 APAC Olanzapine Tablets Sales by Region (2018-2023)
6.1.2 APAC Olanzapine Tablets Revenue by Region (2018-2023)
6.2 APAC Olanzapine Tablets Sales by Type
6.3 APAC Olanzapine Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Olanzapine Tablets by Country
7.1.1 Europe Olanzapine Tablets Sales by Country (2018-2023)
7.1.2 Europe Olanzapine Tablets Revenue by Country (2018-2023)
7.2 Europe Olanzapine Tablets Sales by Type
7.3 Europe Olanzapine Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Olanzapine Tablets by Country
8.1.1 Middle East & Africa Olanzapine Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Olanzapine Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Olanzapine Tablets Sales by Type
8.3 Middle East & Africa Olanzapine Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Olanzapine Tablets
10.3 Manufacturing Process Analysis of Olanzapine Tablets
10.4 Industry Chain Structure of Olanzapine Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Olanzapine Tablets Distributors
11.3 Olanzapine Tablets Customer
12 World Forecast Review for Olanzapine Tablets by Geographic Region
12.1 Global Olanzapine Tablets Market Size Forecast by Region
12.1.1 Global Olanzapine Tablets Forecast by Region (2024-2029)
12.1.2 Global Olanzapine Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Olanzapine Tablets Forecast by Type
12.7 Global Olanzapine Tablets Forecast by Application
13 Key Players Analysis
13.1 Lilly
13.1.1 Lilly Company Information
13.1.2 Lilly Olanzapine Tablets Product Portfolios and Specifications
13.1.3 Lilly Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Lilly Main Business Overview
13.1.5 Lilly Latest Developments
13.2 Dr. Reddy's Laboratories
13.2.1 Dr. Reddy's Laboratories Company Information
13.2.2 Dr. Reddy's Laboratories Olanzapine Tablets Product Portfolios and Specifications
13.2.3 Dr. Reddy's Laboratories Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Dr. Reddy's Laboratories Main Business Overview
13.2.5 Dr. Reddy's Laboratories Latest Developments
13.3 Apotex
13.3.1 Apotex Company Information
13.3.2 Apotex Olanzapine Tablets Product Portfolios and Specifications
13.3.3 Apotex Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Apotex Main Business Overview
13.3.5 Apotex Latest Developments
13.4 Torrent Pharmaceuticals Ltd.
13.4.1 Torrent Pharmaceuticals Ltd. Company Information
13.4.2 Torrent Pharmaceuticals Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.4.3 Torrent Pharmaceuticals Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Torrent Pharmaceuticals Ltd. Main Business Overview
13.4.5 Torrent Pharmaceuticals Ltd. Latest Developments
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Information
13.5.2 Teva Pharmaceutical Olanzapine Tablets Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Main Business Overview
13.5.5 Teva Pharmaceutical Latest Developments
13.6 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.6.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
13.6.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.6.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
13.6.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
13.7 QILU Pharmaceutical Co., Ltd.
13.7.1 QILU Pharmaceutical Co., Ltd. Company Information
13.7.2 QILU Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.7.3 QILU Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 QILU Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 QILU Pharmaceutical Co., Ltd. Latest Developments
13.8 Changzhou Watson Pharmaceuticals Co., Ltd.
13.8.1 Changzhou Watson Pharmaceuticals Co., Ltd. Company Information
13.8.2 Changzhou Watson Pharmaceuticals Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.8.3 Changzhou Watson Pharmaceuticals Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Changzhou Watson Pharmaceuticals Co., Ltd. Main Business Overview
13.8.5 Changzhou Watson Pharmaceuticals Co., Ltd. Latest Developments
13.9 Sichuan Kelun Pharmaceutical Co.,Ltd.
13.9.1 Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
13.9.2 Sichuan Kelun Pharmaceutical Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.9.3 Sichuan Kelun Pharmaceutical Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sichuan Kelun Pharmaceutical Co.,Ltd. Main Business Overview
13.9.5 Sichuan Kelun Pharmaceutical Co.,Ltd. Latest Developments
13.10 Zhejiang Huahai Pharmaceutical Co., Ltd.
13.10.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
13.10.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.10.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Latest Developments
13.11 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
13.11.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Information
13.11.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.11.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Main Business Overview
13.11.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Latest Developments
13.12 PKU HealthCare Corp.,Ltd.
13.12.1 PKU HealthCare Corp.,Ltd. Company Information
13.12.2 PKU HealthCare Corp.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.12.3 PKU HealthCare Corp.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 PKU HealthCare Corp.,Ltd. Main Business Overview
13.12.5 PKU HealthCare Corp.,Ltd. Latest Developments
13.13 Chengdu Easton Biopharmaceuticals Co.,Ltd.
13.13.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Information
13.13.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.13.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Main Business Overview
13.13.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Latest Developments
13.14 Sunshine Lake Pharma Co., Ltd.
13.14.1 Sunshine Lake Pharma Co., Ltd. Company Information
13.14.2 Sunshine Lake Pharma Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.14.3 Sunshine Lake Pharma Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sunshine Lake Pharma Co., Ltd. Main Business Overview
13.14.5 Sunshine Lake Pharma Co., Ltd. Latest Developments
13.15 Hefei Yingtai Pharmaceutical Co., Ltd.
13.15.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.15.2 Hefei Yingtai Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.15.3 Hefei Yingtai Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.16 Suzhou No.3 Pharmaceutical Factory Co.,Ltd.
13.16.1 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Company Information
13.16.2 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.16.3 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Main Business Overview
13.16.5 Suzhou No.3 Pharmaceutical Factory Co.,Ltd. Latest Developments
13.17 Jiangsu Haian Pharmaceutical Co., Ltd.
13.17.1 Jiangsu Haian Pharmaceutical Co., Ltd. Company Information
13.17.2 Jiangsu Haian Pharmaceutical Co., Ltd. Olanzapine Tablets Product Portfolios and Specifications
13.17.3 Jiangsu Haian Pharmaceutical Co., Ltd. Olanzapine Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Jiangsu Haian Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Jiangsu Haian Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

LP Information 社の最新刊レポート

本レポートと同じKEY WORD（tablets）の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/27　10:27

146.53 円

164.06 円

199.13 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.